Dear colleagues!

The study of molecular mechanisms of tumor cell death and survival is of great interest for the creation of new methods of diagnostics and optimization of anti-cancer therapy. New genetic and epigenetic abnormalities in tumor cells applicable for use in clinical practice are frequently reported nowadays. Russian Cancer Research Centers and specialized faculties in universities form the basis for successful studies in the field of tumor cell properties and anti-cancer treatment here, in Russia.

Since 2015, Research Institute of –°arcinogenesis, FSBI " N. N. Blokhin NMRCO" of the Ministry of Health of the Russian Federation, holds annual conferences on Molecular Oncology with the participation of leading experts from Russia and Europe working in the field of cancer research.

16-18 December 2019 Research Institute of Carcinogenesis invite you and your colleagues to participate in The 5-th Russian Conference on Molecular Oncology, which involves the presentations of leading Russian scientists and foreign experts from the United States, Germany, Belgium, France, Latvia, Armenia.

The conference programme includes the following sections:

  1. Genomics and Epigenomics of malignant neoplasms;
  2. Molecular mechanisms of tumor progression and metastasis;
  3. Factors of carcinogenesis and mechanisms of malignant transformation;
  4. Extracellular vesicles in Oncology;
  5. Molecular diagnostics of tumors;
  6. Oncology: fundamental and applied aspects;
  7. Molecular biological approaches to anticancer therapy.

Form of participation:

  • oral report;
  • poster report;
  • abstracts for publication;
  • participation without reports.

The scientific programme of the Conference includes:

  • plenary lectures (20 min);
  • oral presentations (10-15 min);
  • poster presentations.

Abstracts:

Abstracts should be submitted to the organizing Committee of the conference through the personal account from May 20 to October 13, 2019, indicating the desired form of participation.

The Organizing Committee reserves the right to select reports.

Abstracts will be published in the journal "Advances in molecular Oncology".